5 documents found, page 1 of 1
Correction to: Surgery of the primary tumor in patients with de novo metastatic...
Brandão, Mariana; Martins-Branco, Diogo; Angelis, Claudia De; Vuylsteke, Peter; Gelber, Richard D.; Damme, Nancy Van; Walle, Lien vanIn the original publication of the article, the following article note has been missed to include. “Mariana Brandão and Diogo Martins-Branco have contributed equally to this work.” The original article has been corrected.
Effectiveness of palbociclib with aromatase inhibitors for the treatment of adv...
Costa, Filipa Alves da; Borges, Fábio Cardoso; Ramos, Adriana; Mayer, Alexandra; Brito, Claudia; Ramos, Catarina; Bernardo, Catarina; Cossito, MarianeBackground: New drugs for locally advanced or metastatic breast cancer have led to clinical benefits, aside with increasing costs to healthcare systems. The current financing model for health technology assessment (HTA) privileges real-world data. As part of the ongoing HTA, this study aimed to evaluate the effectiveness of palbociclib with aromatase inhibitors (AI) and compare it with the efficacy reported in ...
Adjuvant Chemotherapy De-Escalation with Genomic Assay Protocol in Patients wit...
Martins-Branco, Diogo; Cristóvão Ferreira, Sofia; Gouveia, Emanuel; André, Saudade; Esteves, Susana; Brito, Margarida; Moreira, AntónioIntroduction: Genomic assays are useful tools for tailoring adjuvant treatment in early breast cancer. We aimed to analyse the role of an institutional protocol of a genomic assay for chemotherapy de-escalation.Methods: Prospective cohort study of all consecutive women diagnosed with hormone receptor-positive and human epidermal growth factor receptor 2-negative early breast cancer, tested with the 21-gene Recu...
Impact of the COVID-19 pandemic on breast cancer management in Portugal: a cros...
Alpuim Costa, Diogo; Gonçalves Nobre, José Guilherme; Fernandes, João Paulo; Batista, Marta Vaz; Simas, Ana; Sales, Carolina; Gouveia, HelenaIntroduction: Cancer care providers have faced many challenges in delivering safe care for patients during the COVID-19 pandemic. This cross-sectional survey-based study investigated the impact of the pandemic on clinical practices of Portuguese medical oncologists caring for patients with breast cancer. Methods: An anonymous online survey comprising 42 questions gathered information regarding COVID-19 testing,...
Factors associated with the aggressiveness of care at the end of life for patie...
Martins-Branco, Diogo; Lopes, Silvia; Canario, Rita; Freire, Joao; Feio, Madalena; Ferraz-Goncalves, Jose; Sousa, Gabriela; Lunet, Nuno; Gomes, BárbaraIntroduction There is growing concern about the aggressiveness of cancer care at the end of life (ACCEoL), defined as overly aggressive treatments that compromise the quality of life at its end. Recognising the most affected patients is a cornerstone to improve oncology care. Our aim is to identify factors associated with ACCEoL for patients with cancer dying in hospitals. Methods All adult patients with cancer...